Ongoing

• NewVLPlatform:Validation of a new VLP as vaccine platform.
  2020-2021,H2020-INFRAIA-2016-2017
• ARDAT: Accelerating Research and Development for Advanced Therapies.
  2020-2025, IMI2-Call 18
• CARDIOPATCH: Network of Excellence for the development of Advanced Therapies of Myocardial  Infarction treatment based on regenerative medicine and 3D printing.
  2020-2023, SUDOE -2019
• BRAVƎ: Computational biomechanics and bioengineering 3D printing to develop a personalized regenerative biological ventricular assist device to provide lasting functional support to damaged hearts.
  2020-2024, H2020-EU.3.1.3
• CRUZIVAX: Vaccine for Prevention and Treatment of Trypanosoma cruzi infection​.
  2019-2024, H2020-SC1-BHC-2018-2020
• ADDovenom: Novel Snakebite Therapy Platform of Unparalleled Efficacy, Safety and Affordability.
  2020-2024, H2020-FETOPEN-2018-2020 
• TRANSVAC-DS: Design Study for a European Vaccine Infrastructure.
  2019-2022, H2020-INFRADEV-2018-2020
• PfRipr: Further development of a new asexual blood-stage malaria vaccine candidate.
  2019-2021, GHIT-RFP-TRP-2018-001
• PURE: Precisely Patterned Nanofibers for High Performance Bioseparations.
  2020-2024, H2020-FETOPEN-2018-2020 Eur-Com
• MuVHA: Multivalent inactivated vaccine against heartwater in Africa.
  2018-2021, LEAP-AGRI-345
• STACCATO: European Industrial Doctorate for enhancing upstream biopharmaceutical manufactoring process development through single cell analysis.
  2018-2022, H2020-MSCA-ITN-2018
• ProMeTeus: Membrane protein integrated technologies development for drug design.
  2018-2023, H2020-MSCA-RISE-2018
• TRANSVAC2: European Vaccine Research and Development Infrastructure.
  2017-2022, H2020-INFRAIA-2016-2017-730964

Concluded

• CARDIOCONTRACT: Automated Cardiomyocyte Contractility Assay Instrument.
  2018-2020, EUROSTARS-2 - 12529/19/Q
• DiViNe – Sustainable downstream processing of vaccines through incorporation of nanobiotechnologies: novel affinity ligands and biometric membranes.
  2015-2019, H2020-LEIT-BIO-1-635770. Funded by the EU
• INNOVATE - Investigating the Novel Valuable bio-therapeutics and expression systems.
  2014-2017, ERA-IB-2/0007/2013, Funded by the EU
• EDUFLUVAC – Combinatorial immunization strategy to educate the immune system towards cross recognition and coverage against antigenic drift in seasonal influenza virus exposure.
  2013-2017, FP7-HEALTH-2013-INNOVATION. Funded by the EU.
• EPIGENESIS – One Health approach to integrate Guadeloupe research on vector-borne and emerging diseases in the ERA.
  2013-2016, FP7-REGPOT-2012-2013-1, funded by the EU.
• BRAINVECTORS— From Brain Gene Transfer Towards Gene Therapy: Pharmacological Assessment of AAV, CAV and LVV.
  2012-2016, FP7-PEOPLE-2011-IAPP. Funded by the EU.
• SpeCCC - Specialised Cell Carrier Components.
  2012-2015, FP7‐SME‐2012‐315717. Funded by the EU
• NanoGene - Stem cell generation and manipulation by nanoparticle mediated gene transfer for the safe clinical application of gene-modified cells.
  2011-2014, ENMED/0001/2010, funded by EuroNanoMed ERA-Net.
• PREDECT – New Models for Preclinical Evaluation of Drug Efficacy in common solid tumours.
  2011-2016, GRANT AGREEMENT No. 115188, funded by IMI (Innovative Medicines Initiative) Joint Undertaking, funded by EU.
• ComplexINC - New Technologies and Production Tools for Complex Protein Biologics.
  2011-2015, FP7 / SME-targeted research for developing tools and technologies for high-throughput research, funded by EU.
• CAREMI - Cardio Repair European Multidisciplinary Initiative.
  2010-2015, HEALTH-F5-2010-242038, funded by EU
• HYPERLAB - high yield and performance stem cell lab.
  2009-2012, funded by EU (223011)
• BrainCAV: Gene Transfer for Brain Therapy.
  2008-2012, funded by EU (FP7-222992)
• CLINIGENE-NoE: European Network for the Advancement of Clinical Gene Transfer and Therapy.
  2006-2011, LSHB-CT-2006-018933, funded by the EU
• VITROCELLOMICS - Reducing Animal Experimentation in Preclinical Predictive Drug Testing by Human Hepatic in vitro Models Derived from Embryonic Stem Cells.
  2006-2009, funded by EU (LSHB-CT-2006-018940)
• BACULOGENES – Baculovirus Vectors for Gene Therapy.
  2006-2009, FP6 - 2007, funded by the EU
• MARKVAC - Development of marker vaccines, companion diagnostic tests and improvement of epidemiological knowledge to facilitate control of rinderpest and peste des petits ruminants viruses.
  2005-2007, RP/PPR MARKVAC, funded by the EU
• EPIGENEVAC - Epidemiology and new generation vaccines for Ehrlichia and Anaplasma infections of ruminants.
  2005-2009, FP6-003713-INCO-DEV-1, funded by the EU
• CELLPROM - Cell Programming by Nanoscaled Devices.
  2004-2009, NMP4-CT-2004-500039, funded by the EU
• INSERTAGENE - Integrated Strategies for efficient therapeutic retrovirus based on modular cell lines.
  2003-2005, QLK3-CT-2002-01949, funded by the EU
• ROTASAFE - Novel strategies for a safe rotavirus vaccine.
  2003-2005, QLRT-2001-01249, funded by the EU
• COWDRIA - Mass production of Cowdria ruminantium to produce a cost effective veterinary vaccine against heartwater.
  2001-2004, 8-ACP-TPS-040, funded by the EU
• ORALVAC - Development of Oral Vaccines, Role of Wildlife in The Maintenance of these Diseases.
  2001-2004, ICA4-CT-2000-30027, funded by the EU